IMDX INSIGHT MOLECULAR DIA INC revenue, earnings and financials
For the quarter ended June 30, 2026, INSIGHT MOLECULAR DIA INC reported revenue of $239K (down 53.9% from a year earlier), net income of −$11.3M and diluted EPS of −$0.31; over the last four quarters revenue was $1.67M and net income $813K; for the fiscal year ended December 2025 revenue was $4.06M, up 115.6% on the year before.
IMDX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $4.06M, gross profit $2.30M, operating income −$51.1M, net income −$50.2K (margin -1.2%), EPS −$1.65
- Fiscal year ended Dec 2024: revenue $1.88M, gross profit $740K, operating income −$61.0M, net income −$60.7K (margin -3.2%), EPS −$4.66
- Fiscal year ended Dec 2023: revenue $1.50M, gross profit $413K, operating income −$25.1M, net income −$27.8K (margin -1.8%), EPS −$3.75
- Fiscal year ended Dec 2022: revenue $958K, gross profit −$18.0K, operating income −$18.0M, net income −$72.9M (margin -7609.8%), EPS −$13.25
- Fiscal year ended Dec 2021: revenue $2.20M, gross profit $1.42M, operating income −$53.7M, net income −$64.1M (margin -2916.2%), EPS −$0.72
IMDX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $239K (down 53.9% year over year), net income −$11.3M, EPS −$0.31
- Quarter ended Mar 31, 2026: revenue $32.0K (down 98.5% year over year), net income −$4.29M, EPS −$0.12
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.14M (down 23.4% year over year), net income $27.2M, EPS −$0.75
- Quarter ended Sep 30, 2025: revenue $260K (up 126.1% year over year), net income −$10.9M, EPS −$0.34
- Quarter ended Jun 30, 2025: revenue $518K (up 398.1% year over year), net income −$9.74M, EPS −$0.30
- Quarter ended Mar 31, 2025: revenue $2.14M (up 1114.8% year over year), net income −$6.67M, EPS −$0.26
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.49M (up 373.2% year over year), net income $27.1M, EPS −$2.19
- Quarter ended Sep 30, 2024: revenue $115K (down 73.2% year over year), net income −$13.5M, EPS −$0.98
- Quarter ended Jun 30, 2024: revenue $104K (down 77.5% year over year), net income −$4.53M, EPS −$0.36
- Quarter ended Mar 31, 2024: revenue $176K (down 40.7% year over year), net income −$9.13M, EPS −$1.13
- Quarter ended Dec 31, 2023 (from the annual report): revenue $314K (up 14.6% year over year), net income $11.8M, EPS −$2.27
- Quarter ended Sep 30, 2023: revenue $429K (up 540.3% year over year), net income −$6.49M, EPS −$0.81
- Quarter ended Jun 30, 2023: revenue $463K (up 95.4% year over year), net income −$8.33M, EPS −$1.07
- Quarter ended Mar 31, 2023: revenue $297K (down 21.8% year over year), net income $3.03M, EPS $0.40
- Quarter ended Dec 31, 2022 (from the annual report): revenue $274K (down 92.4% year over year), net income −$45.0M, EPS −$10.04
- Quarter ended Sep 30, 2022: revenue $67.0K (down 93.2% year over year), net income −$9.33M, EPS −$1.62
- Quarter ended Jun 30, 2022: revenue $237K (down 88.3% year over year), net income −$8.30M, EPS −$1.48
- Quarter ended Mar 31, 2022: revenue $380K (down 66.2% year over year), net income −$10.3M, EPS −$0.11
- Quarter ended Dec 31, 2021: revenue $3.59M, net income −$35.9M, EPS −$0.64
- Quarter ended Sep 30, 2021: revenue $984K, net income −$13.8M, EPS −$0.15
IMDX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$22.2M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$20.7M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$23.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$45.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$35.9M, share buybacks n/a
IMDX balance sheet
- Jun 30, 2026: cash $17.8M, total assets $29.4M, total liabilities $50.7M, shareholders' equity −$21.3M
- Mar 31, 2026: cash $28.2M, total assets $40.4M, total liabilities $51.1M, shareholders' equity −$10.7M
- Dec 31, 2025: cash $11.6M, total assets $25.8M, total liabilities $57.2M, shareholders' equity −$31.5M
- Sep 30, 2025: cash $18.7M, total assets $43.9M, total liabilities $53.1M, shareholders' equity −$9.20M
- Jun 30, 2025: cash $24.3M, total assets $50.5M, total liabilities $49.4M, shareholders' equity $1.10M
- Mar 31, 2025: cash $31.0M, total assets $60.4M, total liabilities $50.1M, shareholders' equity $10.2M
- Dec 31, 2024: cash $8.64M, total assets $35.1M, total liabilities $47.4M, shareholders' equity −$12.3M
- Sep 30, 2024: cash $3.36M, total assets $70.2M, total liabilities $60.5M, shareholders' equity $9.71M
What is IMDX's revenue?
INSIGHT MOLECULAR DIA INC reported $1.67M of revenue over its last four quarters, through June 30, 2026.
Is IMDX profitable?
Yes. INSIGHT MOLECULAR DIA INC earned $813K over the last four quarters.
What is IMDX's EPS?
Diluted earnings per share over the last four quarters were −$1.52; −$0.31 in the latest quarter.